▶ 調査レポート

3Dプリンター製医薬品の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global 3D Printed Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。3Dプリンター製医薬品の世界市場2020年:メーカー別、地域別、種類・用途別 / Global 3D Printed Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A9800資料のイメージです。• レポートコード:MRC2012A9800
• 出版社/出版日:GlobalInfoResearch / 2020年12月28日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、3Dプリンター製医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。3Dプリンター製医薬品の種類別市場規模(スプリタム、その他)、用途別市場規模(子供、高齢者、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Aprecia Pharmaceuticals、FabRX、GlaxoSmithKline、Revolution Medicines、
・地域別グローバル市場分析 2015年-2020年
・3Dプリンター製医薬品の北米市場(アメリカ、カナダ、メキシコ)
・3Dプリンター製医薬品のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・3Dプリンター製医薬品のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・3Dプリンター製医薬品の南米市場(ブラジル、アルゼンチン)
・3Dプリンター製医薬品の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:スプリタム、その他
・用途別分析:子供、高齢者、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The 3D Printed Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global 3D Printed Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 262.8 million by 2025, from USD 228.7 million in 2019.

Market segmentation
3D Printed Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, 3D Printed Drugs market has been segmented into
Spritam
Others

By Application, 3D Printed Drugs has been segmented into:
Children
Elderly
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global 3D Printed Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level 3D Printed Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global 3D Printed Drugs market.

The report offers in-depth assessment of the growth and other aspects of the 3D Printed Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and 3D Printed Drugs Market Share Analysis
3D Printed Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, 3D Printed Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the 3D Printed Drugs sales, revenue and market share for each player covered in this report.

The major players covered in 3D Printed Drugs are:
Aprecia Pharmaceuticals
FabRX
GlaxoSmithKline
Revolution Medicines

Among other players domestic and global, 3D Printed Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 3D Printed Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 3D Printed Drugs, with price, sales, revenue and global market share of 3D Printed Drugs in 2018 and 2019.
Chapter 3, the 3D Printed Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 3D Printed Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, 3D Printed Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe 3D Printed Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 3D Printed Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 3D Printed Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Spritam
1.2.3 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global 3D Printed Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Children
1.3.3 Elderly
1.3.4 Others
1.4 Overview of Global 3D Printed Drugs Market
1.4.1 Global 3D Printed Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Aprecia Pharmaceuticals
2.1.1 Aprecia Pharmaceuticals Details
2.1.2 Aprecia Pharmaceuticals Major Business
2.1.3 Aprecia Pharmaceuticals SWOT Analysis
2.1.4 Aprecia Pharmaceuticals Product and Services
2.1.5 Aprecia Pharmaceuticals 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 FabRX
2.2.1 FabRX Details
2.2.2 FabRX Major Business
2.2.3 FabRX SWOT Analysis
2.2.4 FabRX Product and Services
2.2.5 FabRX 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Revolution Medicines
2.4.1 Revolution Medicines Details
2.4.2 Revolution Medicines Major Business
2.4.3 Revolution Medicines SWOT Analysis
2.4.4 Revolution Medicines Product and Services
2.4.5 Revolution Medicines 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global 3D Printed Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global 3D Printed Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 3D Printed Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 3D Printed Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global 3D Printed Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global 3D Printed Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global 3D Printed Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America 3D Printed Drugs Sales and Growth Rate (2015-2020)
4.3 Europe 3D Printed Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific 3D Printed Drugs Sales and Growth Rate (2015-2020)
4.5 South America 3D Printed Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa 3D Printed Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America 3D Printed Drugs Sales, Revenue and Market Share by Country
5.1.1 North America 3D Printed Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America 3D Printed Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States 3D Printed Drugs Sales and Growth Rate (2015-2020)
5.3 Canada 3D Printed Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico 3D Printed Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe 3D Printed Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe 3D Printed Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe 3D Printed Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany 3D Printed Drugs Sales and Growth Rate (2015-2020)
6.3 UK 3D Printed Drugs Sales and Growth Rate (2015-2020)
6.4 France 3D Printed Drugs Sales and Growth Rate (2015-2020)
6.5 Russia 3D Printed Drugs Sales and Growth Rate (2015-2020)
6.6 Italy 3D Printed Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific 3D Printed Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific 3D Printed Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific 3D Printed Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China 3D Printed Drugs Sales and Growth Rate (2015-2020)
7.3 Japan 3D Printed Drugs Sales and Growth Rate (2015-2020)
7.4 Korea 3D Printed Drugs Sales and Growth Rate (2015-2020)
7.5 India 3D Printed Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia 3D Printed Drugs Sales and Growth Rate (2015-2020)
7.7 Australia 3D Printed Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America 3D Printed Drugs Sales, Revenue and Market Share by Country
8.1.1 South America 3D Printed Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America 3D Printed Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil 3D Printed Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina 3D Printed Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa 3D Printed Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa 3D Printed Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa 3D Printed Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia 3D Printed Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey 3D Printed Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt 3D Printed Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa 3D Printed Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global 3D Printed Drugs Sales and Market Share by Type (2015-2020)
10.2 Global 3D Printed Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global 3D Printed Drugs Price by Type (2015-2020)
11 Global 3D Printed Drugs Market Segment by Application
11.1 Global 3D Printed Drugs Sales Market Share by Application (2015-2020)
11.2 Global 3D Printed Drugs Revenue Market Share by Application (2015-2020)
11.3 Global 3D Printed Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global 3D Printed Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 3D Printed Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America 3D Printed Drugs Market Forecast (2021-2025)
12.2.2 Europe 3D Printed Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific 3D Printed Drugs Market Forecast (2021-2025)
12.2.4 South America 3D Printed Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa 3D Printed Drugs Market Forecast (2021-2025)
12.3 3D Printed Drugs Market Forecast by Type (2021-2025)
12.3.1 Global 3D Printed Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global 3D Printed Drugs Market Share Forecast by Type (2021-2025)
12.4 3D Printed Drugs Market Forecast by Application (2021-2025)
12.4.1 Global 3D Printed Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global 3D Printed Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global 3D Printed Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of 3D Printed Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global 3D Printed Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global 3D Printed Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Aprecia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Aprecia Pharmaceuticals 3D Printed Drugs Major Business
Table 10. Aprecia Pharmaceuticals 3D Printed Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Aprecia Pharmaceuticals SWOT Analysis
Table 12. Aprecia Pharmaceuticals 3D Printed Drugs Product and Services
Table 13. Aprecia Pharmaceuticals 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. FabRX Basic Information, Manufacturing Base and Competitors
Table 15. FabRX 3D Printed Drugs Major Business
Table 16. FabRX 3D Printed Drugs Total Revenue (USD Million) (2018-2019)
Table 17. FabRX SWOT Analysis
Table 18. FabRX 3D Printed Drugs Product and Services
Table 19. FabRX 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 21. GlaxoSmithKline 3D Printed Drugs Major Business
Table 22. GlaxoSmithKline 3D Printed Drugs Total Revenue (USD Million) (2018-2019)
Table 23. GlaxoSmithKline SWOT Analysis
Table 24. GlaxoSmithKline 3D Printed Drugs Product and Services
Table 25. GlaxoSmithKline 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Revolution Medicines Basic Information, Manufacturing Base and Competitors
Table 27. Revolution Medicines 3D Printed Drugs Major Business
Table 28. Revolution Medicines 3D Printed Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Revolution Medicines SWOT Analysis
Table 30. Revolution Medicines 3D Printed Drugs Product and Services
Table 31. Revolution Medicines 3D Printed Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Global 3D Printed Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 33. Global 3D Printed Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 34. Global 3D Printed Drugs Sales by Regions (2015-2020) (K Units)
Table 35. Global 3D Printed Drugs Sales Market Share by Regions (2015-2020)
Table 36. Global 3D Printed Drugs Revenue by Regions (2015-2020) (USD Million)
Table 37. North America 3D Printed Drugs Sales by Countries (2015-2020) (K Units)
Table 38. North America 3D Printed Drugs Sales Market Share by Countries (2015-2020)
Table 39. North America 3D Printed Drugs Revenue by Countries (2015-2020) (USD Million)
Table 40. North America 3D Printed Drugs Revenue Market Share by Countries (2015-2020)
Table 41. Europe 3D Printed Drugs Sales by Countries (2015-2020) (K Units)
Table 42. Europe 3D Printed Drugs Sales Market Share by Countries (2015-2020)
Table 43. Europe 3D Printed Drugs Revenue by Countries (2015-2020) (USD Million)
Table 44. Asia-Pacific 3D Printed Drugs Sales by Regions (2015-2020) (K Units)
Table 45. Asia-Pacific 3D Printed Drugs Sales Market Share by Regions (2015-2020)
Table 46. Asia-Pacific 3D Printed Drugs Revenue by Regions (2015-2020) (USD Million)
Table 47. South America 3D Printed Drugs Sales by Countries (2015-2020) (K Units)
Table 48. South America 3D Printed Drugs Sales Market Share by Countries (2015-2020)
Table 49. South America 3D Printed Drugs Revenue by Countries (2015-2020) (USD Million)
Table 50. South America 3D Printed Drugs Revenue Market Share by Countries (2015-2020)
Table 51. Middle East & Africa 3D Printed Drugs Sales by Countries (2015-2020) (K Units)
Table 52. Middle East & Africa 3D Printed Drugs Sales Market Share by Countries (2015-2020)
Table 53. Middle East & Africa 3D Printed Drugs Revenue by Countries (2015-2020) (USD Million)
Table 54. Middle East & Africa 3D Printed Drugs Revenue Market Share by Countries (2015-2020)
Table 55. Global 3D Printed Drugs Sales by Type (2015-2020) (K Units)
Table 56. Global 3D Printed Drugs Sales Share by Type (2015-2020)
Table 57. Global 3D Printed Drugs Revenue by Type (2015-2020) (USD Million)
Table 58. Global 3D Printed Drugs Revenue Share by Type (2015-2020)
Table 59. Global 3D Printed Drugs Sales by Application (2015-2020) (K Units)
Table 60. Global 3D Printed Drugs Sales Share by Application (2015-2020)
Table 61. Global 3D Printed Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 62. Global 3D Printed Drugs Market Share Forecast by Regions (2021-2025)
Table 63. Global 3D Printed Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 64. Global 3D Printed Drugs Market Share Forecast by Type (2021-2025)
Table 65. Global 3D Printed Drugs Sales Forecast by Application (2021-2025)
Table 66. Global 3D Printed Drugs Market Share Forecast by Application (2021-2025)
Table 67. Direct Channel Pros & Cons
Table 68. Indirect Channel Pros & Cons
Table 69. Distributors/Traders/ Dealers List
List of Figures
Figure 1. 3D Printed Drugs Picture
Figure 2. Global Sales Market Share of 3D Printed Drugs by Type in 2019
Figure 3. Spritam Picture
Figure 4. Others Picture
Figure 5. 3D Printed Drugs Sales Market Share by Application in 2019
Figure 6. Children Picture
Figure 7. Elderly Picture
Figure 8. Others Picture
Figure 9. Global 3D Printed Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey 3D Printed Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global 3D Printed Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global 3D Printed Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 3D Printed Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 3D Printed Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global 3D Printed Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global 3D Printed Drugs Revenue Market Share by Regions in 2018
Figure 38. North America 3D Printed Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe 3D Printed Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific 3D Printed Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America 3D Printed Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa 3D Printed Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America 3D Printed Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America 3D Printed Drugs Sales Market Share by Countries in 2018
Figure 46. North America 3D Printed Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America 3D Printed Drugs Revenue Market Share by Countries in 2018
Figure 48. United States 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe 3D Printed Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe 3D Printed Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific 3D Printed Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific 3D Printed Drugs Revenue Market Share by Regions 2019
Figure 62. China 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America 3D Printed Drugs Sales Market Share by Countries in 2019
Figure 69. South America 3D Printed Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa 3D Printed Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa 3D Printed Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa 3D Printed Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa 3D Printed Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa 3D Printed Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global 3D Printed Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global 3D Printed Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales 3D Printed Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales 3D Printed Drugs Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales 3D Printed Drugs Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales 3D Printed Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales 3D Printed Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel